1. Market Research
  2. > Pharmaceutical
  3. > Drug Discovery and Development Market Trends
  4. > Aneurysm Global Clinical Trials Review, H1, 2015

Aneurysm Global Clinical Trials Review, H1, 2015

  • March 2015
  • -
  • Global Data
  • -
  • 91 pages

Aneurysm Global Clinical Trials Review, H1, 2015

Summary

GlobalData's clinical trial report, “Aneurysm Global Clinical Trials Review, H1, 2015" provides data on the Aneurysm clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Aneurysm. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Aneurysm. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each
- Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type
- Listings of discontinued trials (suspended, withdrawn and terminated)

Reasons to buy

- Understand the dynamics of a particular indication in a condensed manner
- Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more
- Obtain discontinued trial listing for trials across the globe
- Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies

Table Of Contents

Aneurysm Global Clinical Trials Review, H1, 2015
Table of Contents
Table of Contents 2
List of Tables 4
List of Figures 5
Introduction 6
Aneurysm 6
Report Guidance 6
Clinical Trials by Region 7
Clinical Trials and Average Enrollment by Country 8
Top Countries Contributing to Clinical Trials in Asia-Pacific 10
Top Five Countries Contributing to Clinical Trials in Europe 11
Top Countries Contributing to Clinical Trials in North America 12
Top Countries Contributing to Clinical Trials in Middle East and Africa 13
Top Countries Contributing to Clinical Trials in Central and South America 14
Clinical Trials by G7 Countries: Proportion of Aneurysm to Cardiovascular Clinical Trials 15
Clinical Trials by Phase in G7 Countries 16
Clinical Trials in G7 Countries by Trial Status 17
Clinical Trials by E7 Countries: Proportion of Aneurysm to Cardiovascular Clinical Trials 18
Clinical Trials by Phase in E7 Countries 19
Clinical Trials in E7 Countries by Trial Status 20
Clinical Trials by Phase 21
In Progress Trials by Phase 22
Clinical Trials by Trial Status 23
Clinical Trials by End Point Status 24
Unaccomplished Trials of Aneurysm 25
Subjects Recruited Over a Period of Time 28
Clinical Trials by Sponsor Type 29
Prominent Sponsors 30
Top Companies Participating in Aneurysm Therapeutics Clinical Trials 31
Prominent Drugs 32
Clinical Trial Profiles 33
Clinical Trial Overview of Top Companies 33
Novartis AG 33
Clinical Trial Overview of Novartis AG 33
NoNO, Inc. 34
Clinical Trial Overview of NoNO, Inc. 34
Sanofi 35
Clinical Trial Overview of Sanofi 35
Johnson and Johnson 36
Clinical Trial Overview of Johnson and Johnson 36
Hope Pharmaceuticals, Inc. 37
Clinical Trial Overview of Hope Pharmaceuticals, Inc. 37
Fresenius Kabi AG 38
Clinical Trial Overview of Fresenius Kabi AG 38
Edge Therapeutics, Inc. 39
Clinical Trial Overview of Edge Therapeutics, Inc. 39
Clinical Trial Overview of Top Institutes / Government 40
Leiden University Medical Center 40
Clinical Trial Overview of Leiden University Medical Center 40
Assistance Publique - Hopitaux de Paris 41
Clinical Trial Overview of Assistance Publique - Hopitaux de Paris 41
Nihon University 42
Clinical Trial Overview of Nihon University 42
Tohoku University School of Medicine 43
Clinical Trial Overview of Tohoku University School of Medicine 43
Academic Medical Center 44
Clinical Trial Overview of Academic Medical Center 44
Centre Hospitalier Universitaire de Nice 45
Clinical Trial Overview of Centre Hospitalier Universitaire de Nice 45
Duke University 46
Clinical Trial Overview of Duke University 46
Hospital Israelita Albert Einstein 47
Clinical Trial Overview of Hospital Israelita Albert Einstein 47
Imperial College London 48
Clinical Trial Overview of Imperial College London 48
James Cook University 49
Clinical Trial Overview of James Cook University 49
Five Key Clinical Profiles 50
Appendix 89
Abbreviations 89
Definitions 89
Research Methodology 90
Secondary Research 90
About GlobalData 91
Contact Us 91
Disclaimer 91
Source 91

List of Tables
Aneurysm Therapeutics, Global, Clinical Trials by Region, 2015* 7
Aneurysm Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2015* 8
Aneurysm Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2015* 9
Aneurysm Therapeutics Clinical Trials, Asia-Pacific, Top Countries, 2015* 10
Aneurysm Therapeutics Clinical Trials, Europe, Top Five Countries, 2015* 11
Aneurysm Therapeutics Clinical Trials, North America, Top Countries, 2015* 12
Aneurysm Therapeutics Clinical Trials, Middle East and Africa, Top Countries, 2015* 13
Aneurysm Therapeutics Clinical Trials, Central and South America, Top Countries, 2015* 14
Proportion of Aneurysm to Cardiovascular Clinical Trials, G7 Countries (%), 2015* 15
Aneurysm Therapeutics, G7 Countries, Clinical Trials by Phase, 2015* 16
Aneurysm Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2015* 17
Proportion of Aneurysm to Cardiovascular Clinical Trials, E7 Countries (%), 2015* 18
Aneurysm Therapeutics, E7 Countries, Clinical Trials by Phase, 2015* 19
Aneurysm Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2015* 20
Aneurysm Therapeutics, Global, Clinical Trials by Phase, 2015* 21
Aneurysm Therapeutics, Global, Clinical Trials In Progress by Phase 2015* 22
Aneurysm Therapeutics, Global, Clinical Trials by Trial Status, 2015* 23
Aneurysm Therapeutics Clinical Trials, Global, by End Point Status, 2015* 24
Aneurysm Therapeutics, Global, Suspended Clinical Trials, 2015* 25
Aneurysm Therapeutics, Global, Withdrawn Clinical Trials, 2015* 26
Aneurysm Therapeutics, Global, Terminated Clinical Trials, 2015* 27
Aneurysm Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2010-2014 28
Aneurysm Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2015* 29
Aneurysm Therapeutics Clinical Trials, Global, Key Sponsors, 2015* 30
Aneurysm Therapeutics Clinical Trials, Global, Top Companies by Phase, 2015* 31
Aneurysm Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2015* 32
Aneurysm Therapeutics Clinical Trials Market, Global, Clinical Trials by Novartis AG, 2015* 33
Aneurysm Therapeutics Clinical Trials Market, Global, Clinical Trials by NoNO, Inc., 2015* 34
Aneurysm Therapeutics Clinical Trials Market, Global, Clinical Trials by Sanofi, 2015* 35
Aneurysm Therapeutics Clinical Trials Market, Global, Clinical Trials by Johnson and Johnson, 2015* 36
Aneurysm Therapeutics Clinical Trials Market, Global, Clinical Trials by Hope Pharmaceuticals, Inc., 2015* 37
Aneurysm Therapeutics Clinical Trials Market, Global, Clinical Trials by Fresenius Kabi AG, 2015* 38
Aneurysm Therapeutics Clinical Trials Market, Global, Clinical Trials by Edge Therapeutics, Inc., 2015* 39
Aneurysm Therapeutics Clinical Trials Market, Global, Clinical Trials by Leiden University Medical Center, 2015* 40
Aneurysm Therapeutics Clinical Trials Market, Global, Clinical Trials by Assistance Publique - Hopitaux de Paris, 2015* 41
Aneurysm Therapeutics Clinical Trials Market, Global, Clinical Trials by Nihon University, 2015* 42
Aneurysm Therapeutics Clinical Trials Market, Global, Clinical Trials by Tohoku University School of Medicine, 2015* 43
Aneurysm Therapeutics Clinical Trials Market, Global, Clinical Trials by Academic Medical Center, 2015* 44
Aneurysm Therapeutics Clinical Trials Market, Global, Clinical Trials by Centre Hospitalier Universitaire de Nice, 2015* 45
Aneurysm Therapeutics Clinical Trials Market, Global, Clinical Trials by Duke University, 2015* 46
Aneurysm Therapeutics Clinical Trials Market, Global, Clinical Trials by Hospital Israelita Albert Einstein, 2015* 47
Aneurysm Therapeutics Clinical Trials Market, Global, Clinical Trials by Imperial College London, 2015* 48
Aneurysm Therapeutics Clinical Trials Market, Global, Clinical Trials by James Cook University, 2015* 49

List of Figures
Aneurysm Therapeutics, Global, Clinical Trials by Region (%), 2015* 7
Aneurysm Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2015* 8
Aneurysm Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2015* 9
Aneurysm Therapeutics Clinical Trials, Asia-Pacific, Top Countries (%), 2015* 10
Aneurysm Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2015* 11
Aneurysm Therapeutics Clinical Trials, North America, Top Countries (%), 2015* 12
Aneurysm Therapeutics Clinical Trials, Middle East and Africa, Top Countries (%), 2015* 13
Proportion of Aneurysm to Cardiovascular Clinical Trials, G7 Countries (%), 2015* 15
Aneurysm Therapeutics, G7 Countries, Clinical Trials by Phase, 2015* 16
Aneurysm Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2015* 17
Proportion of Aneurysm to Cardiovascular Clinical Trials, E7 Countries (%), 2015* 18
Aneurysm Therapeutics, E7 Countries, Clinical Trials by Phase, 2015* 19
Aneurysm Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2015* 20
Aneurysm Therapeutics, Global, Clinical Trials by Phase (%), 2015* 21
Aneurysm Therapeutics, Global, Clinical Trials In Progress by Phase, 2015* 22
Aneurysm Therapeutics, Global, Clinical Trials by Trial Status, 2015* 23
Aneurysm Therapeutics Clinical Trials, Global, by End Point Status, 2015* 24
Aneurysm Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2010-2014 28
Aneurysm Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2015* 29
Aneurysm Therapeutics Clinical Trials, Global, Key Sponsors, 2015* 30
Aneurysm Therapeutics Clinical Trials, Global, Top Companies by Phase, 2015* 31
Aneurysm Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2015* 32
GlobalData Methodology 90

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Ahmad

+1 718 618 4302

Purchase Reports From Reputable Market Research Publishers
Clinical Trial Management System Market by End-user, Delivery Mode, Type, Component - Global Forecast to 2021

Clinical Trial Management System Market by End-user, Delivery Mode, Type, Component - Global Forecast to 2021

  • $ 5650
  • Industry report
  • August 2016
  • by MarketsandMarkets

The global clinical trial management system (CTMS) market is estimated to grow at a CAGR of 11.5% from 2016 to 2021, to reach USD 920.0 billion by 2021. The adoption of CTMS software is on the rise across ...

Contract Research Organizations Services Market by Type, Therapeutic Area, End User - Global Forecast to 2021

Contract Research Organizations Services Market by Type, Therapeutic Area, End User - Global Forecast to 2021

  • $ 5650
  • Industry report
  • October 2016
  • by MarketsandMarkets

The global CRO services market is estimated to grow at a CAGR of 7.4% from 2016 to 2021, to reach USD 41.86 billion by 2021 from USD 29.29 billion in 2016. Growth in this market is primarily attributed ...

Clinical Trial Management System (CTMS) - Global Market Outlook (2016-2022)

Clinical Trial Management System (CTMS) - Global Market Outlook (2016-2022)

  • $ 4157
  • Industry report
  • November 2016
  • by Stratistics MRC

According to Stratistics MRC, the Global Clinical Trial Management System (CTMS) market is expected to grow from $493.58 million in 2015 to reach $1118.58 million by 2022 with a CAGR of 12.4%. Huge research ...


ref:plp2015

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.